Skip to main content
Normal View

Community Pharmacy Services

Dáil Éireann Debate, Thursday - 12 March 2015

Thursday, 12 March 2015

Questions (199)

Clare Daly

Question:

199. Deputy Clare Daly asked the Minister for Health the reason a person (details supplied) in Dublin 5 is being denied access to the multiple sclerosis drug treatment, Lemtrada. [10852/15]

View answer

Written answers

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to you.

If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.

Top
Share